KG
Therapeutic Areas
CAMP4 Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CMP-001 | Urea Cycle Disorders | Phase 1/2 |
| CMP-002 | SYNGAP1-related disorder | Preclinical |
| New Discovery Programs | CNS Disorders | Discovery |
| Collaboration Program | Neurodegenerative & Kidney Diseases | Discovery |